Fibrosis: all 1,270 studies
Page 8 of 13. Open to participants first (276), then studies with results posted, then the rest; newest registration first within each.
- Characterization of Two Novel Mutations in the Apob GeneStatus unknownNCT03963037
- Ventriculo-arterial Coupling in CirrhoticsCompletedNCT03948659
- Effects of a Novel Physical Exercise Program in Patients With Cirrhosis (the LFN-exercise Protocol)CompletedNCT03932552Not applicable
- Bacterial Infections in Patients with Cirrhosis in Argentina: Clinical and Microbiological CharacteristicsCompletedNCT03919032
- Branched-chain Amino Acid Supplementation for Hepatocellular CarcinomaWithdrawnNCT03908255Phase 2
- Liver and the Spleen Stifness in Adult Patients With Gaucher's Disease Using Ultrasound Shear Wave ElastographyTerminatedNCT03896607
- MPN-RC 118 AVID200 in MyelofibrosisCompletedNCT03895112Phase 1
- Hepatocyte-specific Versus Extracellular Contrast Agents for Liver MRI: Prospective, Intra-individual Comparison of Diagnostic Performance for Hepatocellular CarcinomaStatus unknownNCT03892681Not applicable
- Defining 'Normal' Liver Function Tests & FibroScan Values in PregnancyStatus unknownNCT03883789
- Functional Assessment in Liver TransplantationTerminatedNCT03870568
- Preoperative Portal and Splanchnic Flow Measurement Using MRIStatus unknownNCT03868397Not applicable
- Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated CirrhosisCompletedNCT03855956Not applicable
- Probiotics in the Prevention of Hepatocellular Carcinoma in CirrhosisStatus unknownNCT03853928Not applicable
- A Pathophysiological Study of the Postprandial Human Liver (PLS)CompletedNCT03849235Not applicable
- OCR002-SP103 - Oral Immediate Release StudyCompletedNCT03846843Phase 1
- Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LCStatus unknownNCT03838250Phase 1
- Microvesicles and Monocytes to Predict Mortality of Patients with CirrhosisCompletedNCT03837444
- A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver CirrhosisTerminatedNCT03827200Phase 2
- FibroScan ® Study: Assessing Liver Fibrosis in Patients Using Methotrexate for PsoriasisWithdrawnNCT03820934Not applicable
- Evaluation of Kidney Graft's Fibrosis With Real Time Shear-wave ElastographyCompletedNCT03819400
- Role of Eosinophil in Fibrogenesis of Systemic SclerosisCompletedNCT03816189
- Validation of Point of Care Liver Function TestsTerminatedNCT03800069
- TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)Status unknownNCT03798119Phase 4
- Pathology and Imaging in Kidney AllograftsTerminatedNCT03780101
- Prediction System of Clinical Endpoint Events for Chronic Hepatitis B PatientsActive, not recruitingNCT03777969
- A Prospective Study to Monitor Liver Diseases Dynamically by Ultrasound ViscoelasticityStatus unknownNCT03777293Not applicable
- Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.Status unknownNCT03775798
- Repeatability and Reproducibility of Multiparametric MRICompletedNCT03743272
- EYE-Mobile TRACKer IN the Diagnosis of Minimal Hepatic EncephalopathyStatus unknownNCT03732118
- A Self Selected Population Study of Undiagnosed NAFLD and NASH, Using an Echosens FibroScan, in at Risk PopulationsCompletedNCT03726827
- Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal HypertensionStatus unknownNCT03720067Phase 2/3
- Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear FluidsCompletedNCT03706846Not applicable
- "Early TIPS" Versus Glue Obliteration to Prevent Rebleeding From Gastric VaricesCompletedNCT03705078Not applicable
- Colchicine for Patients With Chagas´ Disease( B1 Stage)Status unknownNCT03704181Phase 2
- The Compliance and Prognosis of NSBB Secondary Prevention of Cirrhosis With Gastroesophageal Varices BleedingStatus unknownNCT03683121
- Study Of Bacterial/Fungal Infections in Hospitalized Patients With Liver Cirrhosis in ChinaStatus unknownNCT03676777
- Biliary Complications in Live Donor Liver TransplantationCompletedNCT03673033
- Pentoxifylline Effect in Patients With Diabetic Nephropathy.(PENFOSIDINE STUDY)Status unknownNCT03664414Phase 4
- Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVRCompletedNCT03659058Not applicable
- Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated CirrhosisActive, not recruitingNCT03654053Phase 3
- The Effect of Rifaximin on Portal Vein ThrombosisStatus unknownNCT03631147Not applicable
- Mesenchymal Stem Cell Therapy for Liver CirrhosisStatus unknownNCT03626090Phase 1/2
- Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)Status unknownNCT03625726Not applicable
- The Effect of Transjugular Intraheptic Portosystemic Shunt (TIPS) on Gastrointestinal Motility and the Gut MicrobiotaCompletedNCT03599492
- To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected PatientsCompletedNCT03593447Phase 2
- HEAL STUDY (Hepatic Encephalopathy and Albumin Study)CompletedNCT03585257Phase 2
- A Study in Reversing Hepatic Fibrosis or Cirrhosis Related to Hepatitis B Virus and Finding BiomarkersStatus unknownNCT03568578Not applicable
- Tadalafil for Erectile Dysfunction in Patients With CirrhosisCompletedNCT03566914Not applicable
- Immunological Measurement of Aspartate/Alanine AminotransferaseCompletedNCT03562585
- First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver FibrosisCompletedNCT03559166Phase 1
- Assessment of Liver Fibrosis and Prognosis in Chinese Patients With CHB Infection Using STE/STQ ElastographyStatus unknownNCT03530657
- People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsActive, not recruitingNCT03520660Phase 4
- A Trial of Cardiac Injections of iMP Cells During CABG SurgeryStatus unknownNCT03515291Phase 2
- Non-invasive Methods to Predict PHG in CirrhosisCompletedNCT03513900
- Noninvasive Tests to Predict the Presence of Esophageal Varices in Patients With Liver CirrhosisCompletedNCT03513887
- Microbiota Study in Liver Transplanted PatientsCompletedNCT03507140
- Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD TrialCompletedNCT03493204Not applicable
- MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)CompletedNCT03483272
- Prevalence of Sarcopenia and Undernutrition in Patients With Cirrhosis and Abdominal HerniaCompletedNCT03458845
- To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics.Status unknownNCT03448770Not applicable
- Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive AssessmentCompletedNCT03443934
- MRI to Assess the Effect of Non-selective Beta-blocker in Patients With CirrhosisCompletedNCT03438916
- Investigation of the Prevalence of Hepatopulmonary Syndrome in Cirrhosis Patients Caused by Hepatitis B in Western ChinaStatus unknownNCT03435406
- Restrictive Versus Liberal Red Blood Cell Transfusion in Patients of Cirrhosis With Septic ShockWithdrawnNCT03433508Not applicable
- Phase 1 Study of HF-LED-RL in Fitzpatrick Skin Types I to IIIStatus unknownNCT03433222Phase 1
- Ultrasound Elastography Assessment of Spleen and Liver Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt (TIPS) ProcedureCompletedNCT03427164Not applicable
- Growth Hormone Therapy in Liver CirrhosisCompletedNCT03420144Phase 2/3
- Fecal Microbial Transplant for Alcohol Misuse in CirrhosisCompletedNCT03416751Phase 1
- Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With CirrhosisCompletedNCT03407001Early Phase 1
- Modified Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal DisconnectionCompletedNCT03396796Not applicable
- Impact of Chlordecone on Active Chronic HepatitisCompletedNCT03373396Not applicable
- Tips Underdilatation in Patients With CirrhosisStatus unknownNCT03363412Not applicable
- Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant EligibilityStatus unknownNCT03342677Not applicable
- BCAA Supplemental StudyCompletedNCT03339232Not applicable
- Impact of Sofosbuvir and Daclatasvir Concentration on HCV RNACompletedNCT03318887
- Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in CirrhosisCompletedNCT03311152Not applicable
- Influence of Shunt Occlusion on Organ Functions in Hyperammonemic Patients With Cirrhosis Having Porto-systemic Shunt.CompletedNCT03293459Not applicable
- HMB for Denutrition in Patients With Cirrhosis (HEPATIC)CompletedNCT03285217Not applicable
- Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With CirrhosisActive, not recruitingNCT03278925Phase 1
- Noninvasive Diagnostic Platform for Liver Fibrosis and Portal HypertensionStatus unknownNCT03277651
- Long Term Follow-up of Hepatitis C Cured PatientsCompletedNCT03246048
- Combining MRI Steatosis Assessment and Transient Elastography to Improve Liver Fibrosis Diagnosis in Non Alcoholic Fatty Liver DiseaseCompletedNCT03245606
- Assessment of Nutritional Status of Patients With Liver CirrhosisCompletedNCT03242798
- A Study of Safety, Tolerability, and the Effects Two ND-L02-s0201 Have on the BodyCompletedNCT03241264Phase 1
- Effect of Vivomixx® on Neuroinflammation in Patients Withs CirrhosisWithdrawnNCT03236090Not applicable
- Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver TransplantationCompletedNCT03234920Not applicable
- Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH CirrhosisStatus unknownNCT03205345Phase 2
- Prevalence of Osteoporosis and Fractures in Patients With Hepatic Cirrhosis and Investigation of the Associated FactorsStatus unknownNCT03201016
- WFA+M2BP in Evaluation of Portal Hypertension and Clinical Outcome in Patients With Liver CirrhosisStatus unknownNCT03195634
- Evaluation of 'Melody' Paracentesis Device for Ascites TherapyCompletedNCT03191851Not applicable
- Oral Fecal Transplant in CirrhosisCompletedNCT03152188Phase 1
- High Versus Low Target Mean Arterial Pressure in Septic Shock in Critically Ill CirrhoticsCompletedNCT03145168Not applicable
- Efficacy and Safety of Terlipressin With Albumin Versus Midodrine With Albumin Versus Albumin Alone in Prevention of Paracentesis Induced Circulatory Dysfunction in CirrhosisCompletedNCT03144713Not applicable
- A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy ParticipantsCompletedNCT03142165Phase 1
- Infections in Hospitalized Cirrhotic PatientsCompletedNCT03137719
- Recombinant Human Granulocyte Monocyte - Colony Stimulating Factor (GM CSF) for Prevention of Pneumonia in Patients With CirrhosisStatus unknownNCT03123666Not applicable
- Evaluating in Cirrhotics With Refractory Vasoplegia the Effect of Methylene BlueCompletedNCT03120637Phase 4
- Postprandial Liver and Spleen Stiffness Measurements in the Noninvasive Diagnosis of CirrhosisCompletedNCT03087344Not applicable
- Evaluation of Hepatic Fibrosis on Multiparametric MRIStatus unknownNCT03085342Not applicable
- Characterization of Myocardial Interstitial Fibrosis and Cardiomyocyte Hypertrophy by Cardiac MRI in Heart FailureStatus unknownNCT03084679Not applicable